HomeONVO • NASDAQ
add
Organovo Holdings Inc
Previous close
$0.40
Day range
$0.36 - $0.43
Year range
$0.32 - $1.74
Market cap
5.53M USD
Avg Volume
274.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 30.00K | — |
Operating expense | 1.65M | -40.54% |
Net income | -2.55M | 36.18% |
Net profit margin | -8.50K | — |
Earnings per share | — | — |
EBITDA | -2.54M | 37.19% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.17M | -58.33% |
Total assets | 6.75M | -39.49% |
Total liabilities | 3.07M | 13.64% |
Total equity | 3.68M | — |
Shares outstanding | 15.37M | — |
Price to book | 1.67 | — |
Return on assets | -80.37% | — |
Return on capital | -101.87% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.55M | 36.18% |
Cash from operations | -2.64M | 16.10% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | -371.00K | — |
Net change in cash | -3.01M | 3.95% |
Free cash flow | -1.56M | 11.89% |
About
Organovo Holdings, Inc. is an early-stage medical laboratory and research company which designs and develops functional, three dimensional human tissue for medical research and therapeutic applications. Organovo was established in 2007 and is headquartered in San Diego, California. The company uses its internally developed NovoGen MMX Bioprinter for 3D bioprinting. Wikipedia
Founded
2007
Website
Employees
19
